P&G Deep-Dive Value Research Report

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow high is its market ceiling? Is it enlarging an existing pie, or creating an entirely new market?5/10

  A

  The ceiling is high, but the essence is "enlarging and defending an already-mature existing pie," not creating a new market—and this is exactly where it first shows weakness when measured against Baillie Gifford's LTGG "fivefold in ten years" yardstick.

  First, lay out the plate. P&G focuses on about 10 daily-staples categories, with total sales of $84.284 billion on an FY2025 basis. Across its five business units, Fabric & Home Care is the largest at about 35% (the roughly $29.6 billion Fabric & Home Care unit is precisely $29.617 billion; next is Baby/Feminine/Family Care at about $20.248 billion, and Beauty at about $14.964 billion). The report says it serves "close to 5 billion consumers" and operates in about 70 countries—in other words, its addressable market is already nearly saturated geographically and demographically, and the remaining room is "selling a bit more, and selling at higher prices, in markets already penetrated," rather than "opening up a brand-new demand from scratch."

  This stands in sharp contrast to the kind of names Baillie Gifford favors. LTGG looks for companies whose "market ceiling keeps being pushed upward"—either turning a small pond into an ocean (like e-commerce versus retail), or using technology to create demand that did not previously exist. The laundry detergent, diapers, razors, and toothpaste P&G sells are daily necessities humanity has used for over a century, and the global home-care and personal-care industry itself grows at only mid-single digits or even lower. The report's own framing is honest: revenue CAGR from FY2020 to FY2025 was "about 3.5%," and FY2025 net sales were essentially flat year over year, with organic sales up just 2%. A market with a ceiling that is still high and still rising rapidly would not see its leader post only 2%–3% organic growth.

  More importantly, its current moves point precisely toward "narrowing focus on the existing pie" rather than "expanding into new territory." In June 2025 the company announced it would, over two years, cut about 7,000 jobs (roughly 6%) and exit certain categories in certain markets, having already exited the Argentine market, restructured its Nigeria business, and divested regional hair-care and personal-care brands in China/Latin America/Europe. This is a mature leader "pruning branches and raising per-unit returns"—thickening the pie rather than enlarging it. A truly high-ceiling growth company would not, at this stage, proactively cut businesses and exit markets.

  So the conclusion is: P&G's "ceiling" manifests as high certainty and strong cash flow within an existing market, not as incremental space. It is enlarging and refining an existing pie that is already largely mature globally, and it is creating almost no new markets. From Baillie Gifford's "fivefold in ten years" perspective, it cannot score high on this question—not because the company is bad, but because the structure of its arena determines its upper bound. What's there is there and what's not is not: the market ceiling of a mature household-and-personal-care leader is simply outside LTGG's range.

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Is growth driven mainly by volume, price, or new businesses?3/10

  A

  Almost impossible. Doubling revenue in five years implies a compound growth rate of about 15% a year, whereas P&G's real growth is mid-single-digit organic growth of "about 1 point from volume, about 1 point from price/mix"—neither volume nor price can supply the momentum a doubling requires, and there is no new business of meaningful scale to take the baton.

  First, quantify "doubling" using the report and first-hand data. To double in five years, revenue CAGR needs to be about 14.9%. But P&G's reality is: FY2025 net sales were essentially flat year over year, with organic sales up just 2%, of which "higher pricing and organic volume each contributed 1 point." The report's trailing-12-month revenue (through 2026-03) of about $86.717 billion (stockanalysis' current TTM figure is $86.72 billion, consistent with the report) would have to reach about $173 billion within five years—the equivalent of conjuring up another present-day P&G out of thin air in a mature global market that grows only mid-single-digit to begin with. That does not hold structurally.

  Unpack the three drivers—volume, price, new business—one by one:

  • Volume: this is the biggest bottleneck. P&G's volume growth has long been only 0–2 points, and the report explicitly lists "whether organic volume stays persistently negative" as the single most important warning indicator, candidly acknowledging contraction and share pressure in some categories, especially the Greater China market. An everyday-goods portfolio in which the world's households are basically fully penetrated cannot sustain double-digit volume growth by selling a few more bottles of detergent.

  • Price/mix: price increases over 2022–2025 were indeed the main driver of profit recovery, but the report judges P&G's pricing power to be "present, but limited"—not every price increase can be passed through painlessly, and elasticity differs greatly by category and region. Doubling five-year revenue on price alone would mean prices cumulatively doubling, which would push volume straight toward private labels and local rivals—self-contradictory.

  • New business: P&G is not in a "second-curve ramp" phase; on the contrary, it is subtracting. The restructuring announced in June 2025 to cut about 7,000 jobs over two years and exit some categories in some markets, layered with about $600 million of tariff headwind in FY2026, points toward contraction and focus rather than the expansion of a new growth pole. The report discloses FY2025 net acquisition spending of only about $11 million—M&A restrained to nearly zero, so there is no path to double via bolt-on acquisitions either.

  Cross-check: management's and the sell-side's own expectations for P&G are low-speed. The current share price implies a forward P/E of about 21.5x, with forward and TTM nearly identical (TTM EPS about $6.84), and the analyst consensus price is about $163.8 (about +10% above the current price)—the market is pricing "stable single-digit compounding," and no one is betting on a "five-year doubling."

  So the honest answer to this question is: the probability of P&G's revenue doubling over the next five years is near zero; its growth is driven jointly by volume (about +1 point) and price/mix (about +1 point), totaling mid-single-digit, with no new business to take the baton, let alone a doubling. This is precisely one of the items where a mature consumer leader must lose points when measured on Baillie Gifford's growth yardstick—its value lies in certainty, not explosiveness.

  Jun 10, 2026
• QFive years out, what will take the baton as the next growth engine? Does this "second curve" exist today?4/10

  A

  P&G has no independent, meaningful-scale "second curve"—what takes the baton five years out will most likely still be today's main curve itself (the "innovation + premium mix + productivity" extension of core everyday categories), not a new growth engine. This is precisely the structural reason it does not fit the Baillie Gifford growth narrative.

  Baillie Gifford asks "whether the second curve exists today," aiming to find the kind of new species "being incubated beyond the main business that can independently carry growth five years out." Measured with this yardstick, the answer for P&G is no. There are three layers of reasons, all grounded in the report and first-hand disclosures:

  First, its "growth engine" is always a different gear of the same machine, not a new engine. The report repeatedly points out that P&G's profit and growth rely on the whole set of operating moves of "productivity savings, premium mix, innovation, distribution gains"—running existing brands more efficiently and selling them at higher price points, which is deep excavation of the main curve, not opening a new battlefield laterally. FY2025 organic sales grew just 2% and net sales were essentially flat, showing this machine outputs a stable mid-single-digit rather than the "old business as ballast, new business taking off" dual-curve form.

  Second, the company's current strategic action is "contract and focus," the opposite of nurturing a second curve. The restructuring announced in June 2025 will, within two years, cut about 7,000 jobs (about 6%) and exit some categories in some markets, having already exited Argentina, restructured Nigeria, and divested regional hair-care and personal-care brands in China/Latin America/Europe. A company incubating a second curve would double down on new fields; what P&G is doing is pruning branches and pulling resources back to the most profitable core categories. This is a mature leader's rational choice, but its price is "no second curve."

  Third, where capital is allocated also proves no new engine is under construction. The report discloses FY2025 net acquisition spending of only about $11 million, with cash flowing mainly to dividends and buybacks—in April 2026 the company just completed its 70th consecutive annual dividend increase. Returning the vast majority of free cash flow to shareholders and making almost no meaningful-scale acquisitions means management judges that "the best place for capital is buying back its own mature cash flows, not investing in a new curve." This is shareholder-friendly discipline, but it also plainly signals: the growth engine is the current one.

  So what takes the baton in five years? The most realistic answer is: still the premiumization and innovation extension of core categories—pricier care bundles, higher-margin health care, the repair of pressured premium categories like SK-II, plus whether the new CEO team (Jejurikar took over effective January 1, 2026) can lift execution efficiency another notch. But these are all extensions of the same curve, not a second curve in the Baillie Gifford sense of "independent, ramp-capable, and able to change the slope of growth."

  Honest conclusion: P&G has no true second curve today, and its growth five years out will still be contributed by the extension of the main business. For a growth investor pursuing a ten-year five-bagger, this is a clear mark against it; for an owner pursuing certain cash flow, this is precisely its other side of "compounding steadily without needing a new story"—both hold, and it depends on which yardstick you use.

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

  A

  The core competitive advantage is a cost-and-distribution moat that combines "brand mindshare + global scale + channel relationships + organizational execution" as a four-in-one; it is broad and deep overall, but its marginal direction over the next three to five years is "stable but slightly narrowing" rather than widening—several categories and the China market have already shown quantifiable share loss.

  First, what the moat is. P&G's advantage does not come from network effects or high switching costs, but from four mutually reinforcing capabilities: (1) a set of high-awareness brands (Tide, Pampers, Gillette, Crest, Oral-B, Always, Charmin, Olay, etc.) that occupy consumer mindshare across multiple high-frequency, must-have categories; (2) scale effects that spread procurement, manufacturing, media spending, and R&D across about 70 countries and close to 5 billion consumers served; (3) deep channel relationships with big retailers like Walmart and with e-commerce, plus shelf-stocking capability; (4) the organizational execution to run brands "as high-return assets" (productivity savings, premium mix, SKU management, global customer coordination).

  The "width" of this moat has hard financials as proof. P&G has maintained an operating margin of about 20%+ for years, an FY2025 gross margin of 51.2%, and the report estimates ROIC of about 20%–22%, with TTM net profit of about $16.3 billion and a net margin of about 19%. Sustaining this level of profitability over the long run through cost shocks, currency swings, and geopolitical disruption is itself evidence of scale and brand converting into pricing power—rivals can replicate a single hit product without much trouble, but replicating P&G's global brand matrix + R&D + supply chain + channels + organization takes years and enormous investment, with a low success rate.

  But on "widen or narrow over the next three to five years," the evidence points to "slightly narrowing," and this must be stated honestly:

  • Share is edging down in several places. The report discloses: FY2025 Beauty global share fell 0.3 points, and Baby/Feminine/Family Care fell 0.2 points; in the first nine months of FY2026, Fabric & Home Care fell 0.2 points and Baby/Feminine/Family Care fell 0.3 points. The magnitude is small, but the direction is consistent—the moat is being continuously eroded at the edges.

  • China and some categories are under structural pressure. FY2025 net sales were essentially flat year over year, with organic sales up just 2%, and both the report and company disclosures name Greater China contraction, intensifying local-brand competition, and weakness in premium categories like SK-II. China is the most dynamic battlefield in global household-and-personal-care, and the rise of local rivals there is the most substantive marginal challenge to a "global-scale moat."

  • Switching costs are inherently weak. A consumer who buys Tide today can buy Persil or a private label tomorrow; someone who uses Gillette today can switch to Schick or Dollar Shave Club tomorrow. Social-media-driven new brands and channel disintermediation make a mindshare moat easier to breach locally than it was a decade ago.

  • The company itself is "contracting to defend." The June 2025 announcement to cut about 7,000 jobs over two years and exit some categories in some markets uses focus to consolidate the core and abandon the periphery—this can hold the deepest part of the moat, but objectively it narrows the front line rather than expanding it outward.

  Overall judgment: P&G's moat remains strong today and will not collapse systemically in the near term, but its marginal direction over three to five years is "solid overall, narrowing locally." It meets Baillie Gifford's requirement for "durable competitive advantage," but not the kind Baillie Gifford values more—"a moat that keeps widening and pushes the ceiling ever higher." For this mature leader, the moat is there to "defend" rather than "expand," and this is the key divide between it and a typical LTGG growth stock.

  Jun 10, 2026
• QIf the core business is disrupted, does it have the DNA to reinvent itself? How does it treat mistakes and bad news?5/10

  A

  P&G is almost never in a situation where "the core business is disrupted overnight," so what it needs is not the "reinvention DNA" of rising from the rubble, but the incremental error-correcting ability of "continuously self-pruning and laying bad news plainly on the table"—and it does this quite solidly and candidly. But this is the discipline of a mature leader, not the kind of regenerative power Baillie Gifford admires in "being reborn under the pressure of crisis."

  First, define the question. Baillie Gifford asks this question of the kind of company "whose main business might be disrupted by technology and that needs to scrape the poison off the bone and start over" (platforms, hardware, drug pipelines). P&G's industry attributes place it outside this context: the report defines it as a mature household-and-personal-care industry that "is not easily disrupted overnight but will be slowly eroded," with technological-disruption risk far lower than software and hardware. So what should really be examined is two things—when facing bad news, does it avoid or confront it? When facing slow erosion, does it dare to operate on itself?

  One, on treating bad news: transparent, unvarnished, proactively writing share declines into disclosure. This is real evidence of P&G's governance maturity. In its segment discussions for FY2025 and the first nine months of FY2026, it does not shy away from the negative: the report cites company disclosures that Beauty share fell 0.3 points, Baby/Feminine/Family Care fell 0.2–0.3 points, Fabric & Home Care fell 0.2 points, the Greater China market contracted, and competitive activity intensified. The "unimpressive" numbers of FY2025 organic sales up just 2% and net sales roughly flat year over year are also published as-is, not papered over with a story. A company willing to lay out for investors, item by item, the share gains and losses of each category, has a healthy attitude toward mistakes and bad news.

  Two, the action to self-prune: using restructuring to proactively cut unprofitable edges. In June 2025, P&G announced it would, within two years, cut about 7,000 jobs (about 6%), exit some categories in some markets, and take a pre-tax charge of about $1.0–1.6 billion, having already exited Argentina, restructured Nigeria, and divested regional hair-care and personal-care brands in China/Latin America/Europe. It also candidly acknowledged about $600 million of tariff headwind in FY2026. This shows it has the discipline to "admit certain businesses aren't working and exit them decisively"—incremental self-correction, not passively waiting to die.

  Three, but this is not "reinvention DNA" in the Baillie Gifford sense. P&G's error correction is "optimization within a mature framework": swapping in a more efficient CEO (Jejurikar took over effective January 1, 2026, groomed internally for over 30 years), cutting costs, raising efficiency, premiumizing. It has not—and does not need to—demonstrate the ability to "start a new fire after the core is disrupted," because its core is almost never disrupted overnight. In other words, its "regenerative capacity" has not been tested by a genuine life-or-death crisis—unlike growth companies that were forced to reinvent in a recent crisis and thereby proved their resilience.

  Honest conclusion: P&G's attitude toward mistakes and bad news is candid and its error-correction discipline is solid (transparent disclosure + proactive restructuring and pruning), but it faces slow erosion rather than disruptive crisis, so it neither needs nor has demonstrated the "reborn-from-the-rubble" reinvention DNA that Baillie Gifford values. It scores high on the "governance integrity" dimension of this question, while the "regenerative explosiveness" dimension does not apply—for a mature leader, the former is the more relevant point of examination.

  Jun 10, 2026
• QDoes management (especially the founder) have a long-term horizon and interests deeply tied to the company? Willing to sacrifice current profit for five to ten years out?4/10

  A

  Management is a highly professional, governance-mature, long-term-aligned team of professional managers—pay tied to the long term, strict share-ownership requirements, orderly succession; but P&G has no founder-style "heavy ownership," and the CEO's personal stake is a tiny fraction of the company, so its alignment comes from "institutional design" rather than from "livelihood on the line." Nor is it the kind of company that would proactively sacrifice current profit and burn cash on the future for a five-to-ten-year vision.

  First, on "long-term horizon and succession." P&G's 2025 leadership change is a textbook orderly handover: Shailesh Jejurikar took over as President and CEO effective January 1, 2026, with former CEO Jon Moeller becoming Executive Chairman. Jejurikar joined P&G in 1989 and served as the company's first COO, with a résumé spanning Fabric Care, Home Care, and Enterprise Markets—a long-groomed internal successor, not an externally parachuted "star CEO." For a conservative long-term investor, this succession style is usually more reliable than betting on a star.

  Next, on "interest alignment," which is quite solid at the institutional level. The report cites the 2025 proxy statement: 89% of NEO total compensation is performance-related, of which 89% is tied to long-term performance; the CEO must hold company stock/RSUs worth at least 8x annual salary, and other NEOs 4x, all met as of June 30, 2025; there are also clawback/recoupment provisions. This is a mature "pay-for-performance + mandatory long-term holding + recoupment mechanism" framework, by no means short-term-cash-out governance.

  But to be honest about the layer Baillie Gifford is really asking about—"founder-style, livelihood deeply tied to the company"—P&G is naturally weak on this dimension:

  • It is a giant founded in 1837 and publicly listed for over a century, having raised its dividend for 70 consecutive years and paid dividends for 136 consecutive years; there is long since no founder or controlling family. Management are professional managers, and the CEO's personal stake is nearly negligible relative to a total market cap on the order of $347 billion. "8x-annual-salary holding" sounds high, but it is still a tiny sliver relative to the company's size. Alignment relies on contracts and metrics, not on the founder-style bind of "if the ship sinks, I'm ruined too."

  • On "willingness to sacrifice current profit for five to ten years out," P&G's answer leans toward "no." Its capital-allocation discipline is to return the vast majority of free cash flow to shareholders (it just completed its 70th consecutive increase in April 2026, and the report discloses FY2025 net acquisition spending of only about $11 million), and to lift current-period efficiency and profit via the two-year restructuring of about 7,000 job cuts announced in June 2025. This is an orientation of "optimizing the present, stabilizing returns," not the founder-style gamble of "suppressing current profit and heavily betting on a distant second curve."

  Overall judgment: P&G management is trustworthy, meeting the bar on both long-term horizon and institutional alignment, and is a model of mature blue-chip governance; but it has no founder-style ownership bind, the degree to which the CEO's personal fortune is deeply tied to the company is low, and it lacks the DNA to "sacrifice current profit for a distant vision." By Baillie Gifford's "founder long-termism" yardstick, it cannot score the highest—this is not a governance flaw but an inherent attribute of a mature professional-manager company: reliable, restrained, but not aggressive.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth sustainable and free of harm to society and regulators?6/10

  A

  If P&G disappeared tomorrow, customers would "miss" it but would not "be unable to find a substitute"—its categories are indispensable, but any single brand is highly replaceable; and its growth is highly sustainable and depends almost not at all on harming society or crossing regulatory red lines. This is a combined answer of "medium indispensability, excellent social and regulatory sustainability."

  This Baillie Gifford question must answer two sub-questions at once: "how much customers would miss it (indispensability)" and "whether growth relies on harming society and regulators (sustainability)." Both must be honestly unpacked.

  First layer · indispensability: the category is essential, the brand is swappable. The needs of laundry, cleaning, oral care, diapers, and shaving are themselves must-haves that consumers cannot go a day without—in this sense, the daily needs of the "close to 5 billion consumers" that P&G serves are indeed indispensable. But whether "P&G the company" is indispensable must be discounted: the report clearly states it has no network effect and no high switching cost—a consumer who buys Tide today can buy Persil or a private label tomorrow, and someone who uses Gillette today can switch to Schick or Dollar Shave Club tomorrow. Share data also corroborates that substitution really happens: the report discloses FY2025 Beauty share fell 0.3 points, Baby/Feminine/Family Care fell 0.2 points, FY2025 organic sales grew just 2%, and Greater China contracted—if P&G disappeared, shelves would be quickly filled by rivals and private labels, and consumers would miss the quality and familiarity of specific products but would not fall into an "irreplaceable" predicament. So indispensability is "high at the category level, medium at the company level."

  Second layer · social and regulatory sustainability: very clean, a real plus. This is P&G's structural advantage relative to many high-growth new-economy companies:

  • Growth does not rely on harming users or society. Its money comes from selling detergent, diapers, and toothpaste—an equal exchange that satisfies real daily needs, with no addictive design, data extraction, regulatory arbitrage, or externality-shifting of the "the faster the growth, the greater the social cost" kind. The report defines it as a mature, stable, non-strongly-cyclical household-and-personal-care industry, with growth coming from the brand premium and efficiency embodied in an FY2025 gross margin of 51.2%, not from harmful means.

  • Regulatory risk is low, governance is transparent. As a legacy blue chip that has paid dividends for 136 consecutive years and raised them for 70 consecutive years, what it faces is mainly routine product safety, environmental, and advertising compliance, not antitrust breakup, platform regulation, or data privacy—systemic risks that could upend a business model. The report's risk disclosures center on share, currency, raw materials, and channels, and almost never touch the tail risk of "regulation possibly banning its business model."

  • The only sustainability point to watch is "routine externalities": packaging plastic and environmental footprint are industry-wide issues, but they are incremental pressures that can be gradually improved through product iteration, not a paradigm problem of "harming society in exchange for growth."

  Overall judgment: if P&G disappeared, customers would miss its product quality but would quickly find substitutes—indispensability is medium; at the same time, its growth is highly sustainable, with a clean social and regulatory backdrop, a good business that "earns money honorably with almost no regulatory tail risk." On the implicit "social license" dimension of Baillie Gifford, it scores very high; but on the irreplaceability of "customers can't live without it," it is only medium—both must be counted truthfully.

  Jun 10, 2026
• QWhat is the unit economics of this business (gross margin, incremental returns)? Does it get better or worse as scale grows? Where does the money it earns go?6/10

  A

  The unit economics are excellent and highly mature: a gross margin of about 51%, an operating margin of about 24%, estimated ROIC of about 20%–22%, and free cash flow that year after year approaches net profit—growing bigger lets it "maintain" high returns rather than "keep getting better," because it has long been on a high plateau of the scale curve. The vast majority of the money it earns is returned to shareholders via dividends and buybacks, not reinvested in new growth.

  First, lay out the hard data on unit economics (all first-hand verified):

  • Gross margin: 51.2% in FY2025, and the report's six-year series shows it stable long-term in the 47%–51% range. For daily consumer goods this is a very high level, reflecting brand premium and procurement/manufacturing scale.

  • Operating margin: on the report's basis, about 24.3% in FY2025 and about 22%–24% long-term, meaning every $100 of goods sold leaves about $24 of operating profit.

  • Return on capital: the report estimates ROIC of about 20%–22% and ROE of about 30% (high because large treasury stock compresses equity, so ROIC is more credible). TTM net profit of about $16.3 billion, net margin of about 19%.

  • Cash conversion: in the report's six-year series, free cash flow was year after year $13.6–16.5 billion, highly matched with net profit, and capex intensity has long been only about 4%–5% of sales. This shows its accounting profit is basically real, distributable cash profit, and incremental growth burns almost no cash.

  "Does it get better or worse as scale grows?"—the answer is "held at a high level, but marginal improvement is already very limited." P&G is not the kind of early growth company where "unit economics jump significantly each time scale doubles"; it has long been the world's largest household-and-personal-care leader, and the scale dividend (spreading procurement, media, distribution) is basically fully cashed in. The evidence is that margins have fluctuated in a narrow band for years rather than kept rising, and FY2025 net sales were essentially flat year over year, with organic sales up just 2%. It relies on productivity savings and premium mix to offset cost inflation and hold margins—a "maintenance-type" rather than "expansion-type" economy of scale. In other words, the marginal return on incremental capital is still very high, but the room for incremental revenue is very small—a good business, but not a "flywheel" that keeps getting better.

  Where does the money it earns go? This is the most critical stroke in P&G's unit-economics story, and the one that most distinguishes it from a growth stock. Its cash goes overwhelmingly to shareholder returns rather than reinvesting for growth: the report discloses FY2025 dividends of about $9.872 billion and buybacks of about $6.5 billion, while net acquisition spending was only about $11 million; in April 2026 the company completed its 70th consecutive annual dividend increase. This means management judges that "the best place for capital is returning mature cash flows to shareholders," not investing in new business. The report's assessment of buybacks is also fair—"competent but not dazzling": from 2020 to 2025 the share count fell only from about 2.480 billion shares to 2.342 billion shares, a decline of about 6%–7%; relative to the large cumulative buyback amount, the per-share accretion is not exactly aggressive.

  Honest conclusion: P&G's unit economics are a model of a top-tier cash cow—high gross margin, high operating margin, ROIC of about 20%, near-1:1 cash conversion; but scale brings "holding onto high returns" rather than "continuous improvement," and the money it earns goes mainly to dividends and buybacks returned to shareholders, not to incubating growth. On Baillie Gifford's "unit economics and incremental returns" dimension, its earnings quality scores high; but the trait Baillie Gifford values more—"a flywheel that grows stronger with scale + reinvesting profit into higher growth"—it does not have. It chooses to give the money back to you, rather than chasing a ten-year five-bagger on your behalf.

  Jun 10, 2026
• QFor it to rise fivefold in ten years, what conditions must hold simultaneously? Are they realistic? What expectations does today's share price imply?2/10

  A

  For P&G to rise fivefold in ten years requires a compound share-price return of about 17.5%/year—for a mature household-and-personal-care leader whose organic growth is only about 2% and whose own report gives an optimistic scenario of just 10%–12%/year, it is nearly impossible to assemble all the required conditions at once. Today's share price of about $149 implies not a "fivefold expectation" but, on the contrary, defensive pricing of "stable mid-single-digit compounding + maintained valuation."

  First, translate "fivefold in ten years" into hard constraints. Fivefold corresponds to an annualized total return of about 17.46%. To achieve this, the following conditions must all hold simultaneously: (1) owner earnings (or EPS) compound at double digits (about 13%–15%) per year over ten years; (2) the valuation does not contract over the period, and ideally even expands; (3) plus about 2.8% of dividend reinvestment, which only barely gets you there. Now check each against reality:

  • Double-digit earnings growth—does not hold. FY2025 net sales were essentially flat year over year, with organic sales up just 2%, and the report gives a 2020–2025 revenue CAGR of about 3.5%. Even the report's most optimistic intrinsic-value scenario assumes owner earnings compounding at only 5%–6% over the next 10 years, corresponding to expected annualized returns of 10%–12%. Even the report's blue-sky case cannot reach double-digit earnings growth, let alone 13%–15%.

  • Valuation expansion—very little room, and the direction is against it. P&G currently trades at a P/E of about 21.8x, TTM EPS of about $6.84, already in the higher range for a mature consumer leader. The report notes its implied owner earnings yield is only about 4.7%, barely above the 10-year Treasury (per the report citing U.S. Treasury data, about 4.56% as of 2026-05-22) and below Aaa corporate bonds at about 5.64%. In a high-rate environment, this "bond substitute" is more likely to be de-rated than given 30x+ to drive a fivefold.

  • Dividend reinvestment—helps but far from enough. Even counting the 70-year consecutive increase and dividend yield of about 2.8%, it lowers the required earnings-growth hurdle from about 14.6% to about 12%, still a pipe dream for a company with +2% organic growth.

  Are these conditions realistic? No. To assemble them, P&G would have to, over ten years, simultaneously: stop share loss in core categories (whereas the reality is Beauty/Baby/Fabric edging down in several places and Greater China contracting), lift organic growth from 2% to double digits (lacking a second curve, and currently cutting about 7,000 jobs in a contractionary restructuring), and the market still willing to keep granting a high valuation. This is a set of mutually contradictory demands—chasing growth via aggressive price hikes loses share, while raising efficiency via contraction suppresses growth; you cannot have both ends.

  So what expectations does today's share price imply? About $149, a market cap of about $347 billion, and a P/E of about 21.8x correspond to the script of "stable mid-single-digit organic growth ahead + continued dividend growth + valuation roughly maintained"—that is, the report's neutral scenario (7%–9% annualized). The analyst consensus price of about $163.8, only about +10% of room, further confirms the market is pricing "quality defensiveness, mild compounding," not "a fivefold explosion in ten years." In other words, there is no fivefold optimism hidden in today's price, nor an obviously undervalued margin of safety—it has already priced the "good company" fairly fully.

  Honest conclusion: the conditions P&G needs to rise fivefold in ten years (double-digit earnings growth + valuation expansion) are almost impossible to hold simultaneously today; the current share price of about $149 implies the defensive expectation of stable mid-single-digit returns, not a growth-style re-rating. This is the most critical and the most honestly-to-be-acknowledged question when measuring it on Baillie Gifford's "fivefold in ten years" yardstick: it is an excellent compounding cash-flow asset, but not a five-bagger candidate in the LTGG sense.

  Jun 10, 2026
• QWhy has the market not yet realized all this? Is it that it can't understand it, looks down on it, or can't see far enough? What would become the "narrative inflection point"?3/10

  A

  This question must be answered in reverse for P&G: the market understands it precisely too well—it is one of the most thoroughly researched and most fully priced blue chips, with no "can't-understand / looks-down-on / can't-see-far" perception gap. Today's price of about $149 and P/E of about 21.8x has already granted the full premium a "quality defensive leader" deserves. The real "narrative inflection point" is more likely negative (growth stalling + multiple compression) than a positive value re-rating.

  The spirit of this Baillie Gifford question is to find a mispriced opportunity where "a great growth fact has not yet been recognized by the market." Applying it honestly to P&G yields a reverse answer: there is no undiscovered perception gap here. The three "can't"s fail one by one:

  • Can't understand? Doesn't exist. P&G is one of the most broadly covered, most densely researched consumer leaders on both the sell-side and buy-side, with 24 analysts covering it, a consensus rating of Buy, and a consensus target of about $163.8 (only about +10% of room). Its business (selling daily necessities) is so simple that even the report gives it "understandability 5/5," with no misread-worthy complexity.

  • Looks down on it? Doesn't exist. On the contrary, the market grants a premium rather than a discount: at the current P/E of about 21.8x, the report calculates an implied owner earnings yield of only about 4.7%—just above the 10-year Treasury at about 4.56%, and even below Aaa corporate bonds at about 5.64%. A stock that is "looked down on" would not trade at a yield below high-grade bonds.

  • Can't see far enough? Also doesn't hold. The market's long-term view of it is quite consistent: FY2025 organic sales up just 2% and a limited growth ceiling are consensus, and the valuation is already priced for "stable mid-single-digit compounding" (the report's neutral scenario of 7%–9% annualized). No one is underestimating its long-term value, and no one is betting on a hidden explosion.

  So where does the real divergence between the report and the market lie? Not in "the market not realizing how good it is," but in "whether buying at the current price still has a margin of safety"—the report's conclusion is "Watch, not cheap enough," on the grounds that the valuation already fully reflects quality and the implied return is compressed by the price. This is a "good company vs. good price" timing divergence, not a "the market hasn't understood the growth story" perception gap.

  "What would become the narrative inflection point?"—for P&G, the inflection is two-way, and the negative possibility is more concrete:

  • Negative inflection (more realistic): if core categories (Fabric Care, Oral Care, Baby Care) see share deteriorate for consecutive quarters, organic volume turns persistently negative, and Greater China stays weak, layered with rates staying high, the market could re-rate the "quality defensive" premium into a discount of an ordinary mature stock. The report roughly estimates: a trailing EPS of $6.84 at 18x corresponds to about $123, at 16x about $109—valuation reversion alone gives 15%–25% downside. The June 2025 announcement to cut about 7,000 jobs over two years, take a charge of about $1.0–1.6 billion, and face about $600 million of tariff headwind in FY2026 is already a footnote to the "growth under pressure" narrative.

  • Positive inflection (weaker): if the new CEO Jejurikar, who took over effective January 1, 2026, turns the restructuring dividend into accelerated organic growth and stabilizes pressured categories like China and SK-II, or if rates fall sharply and make "bond-substitute" cash flows attractive again, the valuation could get support—but this is only a "maintain / mild repair" level of inflection, not enough to drive a Baillie Gifford-style value re-rating.

  Honest conclusion: the market has not "failed to realize" P&G's quality—it has long been fully, even somewhat fully, priced; there is no perception-gap mispricing of the kind Baillie Gifford seeks here. The most likely narrative inflection is instead the negative "growth stalling + multiple compression," with positive catalysts mild and limited. For a growth investor pursuing a ten-year five-bagger, this question plainly signals: P&G's story has been told and priced, leaving almost no room for perception-gap arbitrage.

  Jun 10, 2026